|Please support this
website by purchasing via the links on the website.
Anti-aging Research > Statins >
Where to purchase:
shipping on orders over $250.
News & Research:
Cholesterol Drug Has No Benefit in Trial - New York Times, 1/14/08 -
"About 70 percent of patients who take Zetia do so
in the form of Vytorin, which combines Zetia with the cholesterol drug Zocor
... the plaques actually grew somewhat faster in patients taking Zetia along
with Zocor than in those taking Zocor alone. Patients in the trial who took
the combination of Zetia and Zocor were receiving it in the form of Vytorin
pills ... Patients should not be prescribed Zetia unless all other
cholesterol drugs have failed"
New Study Showed Ezetimibe/Simvastatin Significantly More Effective Than
Rosuvastatin at Lowering LDL Cholesterol at all Doses Compared -
Doctor's Guide, 6/19/06
Combination of Simvastatin/Ezetimibe Reduces C-Reactive Protein Better Than
Simvastatin Alone - Doctor's Guide, 3/15/06 -
"simvastatin was successful in lowering c-reactive
protein values 14.3% from baseline ... the same combination that forms the
cholesterol-lowering drug Vytorin -- reduced c-reactive protein levels 31%"
New Analysis in Patients with Type 2 Diabetes from Trial with Vytorin
(ezetimibe/simvastatin), Presented at ADA - Doctor's Guide, 6/16/05
Vytorin (Ezetimibe/Simvastatin) Improves Markers of Cardiovascular Risk
- Doctor's Guide, 5/2/05 - "Vytorin
(ezetimibe/simvastatin) is more effective than atorvastatin for reducing the
level of atherogenic particles in serum above and beyond its effect on
low-density lipoprotein (LDL) cholesterol"
Dual Cholesterol Agents Vytorin (Ezetimibe/Simvastatin) Effective,
Well-Tolerated in Older Patients
- Doctor's Guide, 3/10/05
Vytorin Slashes Bad Cholesterol to Lower Levels Than Atorvastatin -
Doctor's Guide, 3/9/05
QualityCounts.com Anti-aging Newsletter
Netvibes basic (free)